Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-01-30

Clinical Trial Update: Incretin Hormones in Type-1 Diabetes Mellitus Glycemic Response in Type-1 Diabetes Mellitus

View source ↗

Summary

A completed clinical trial evaluating the effect of incretin hormones on glycemic response in people with Type 1 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hvidovre University Hospital | Conditions: Type 1 Diabetes | Status: COMPLETED